Health Funding Opportunities

blog navigation

All Results

blog posts

  • 2018 Young Investigator Program - Beckman Foundation

    The Arnold and Mabel Beckman Foundation is accepting Letters of Intent for its 2018 Beckman Young Investigator grant program. The annual program is intended to provide research support to the most promising young faculty members in the early stages of an academic career in the chemical or life sciences and to foster the invention of methods, instruments, and materials with the potential to open up new avenues of research in science. Projects proposed for this program should be truly innovative, high-risk, and show promise for contributing to significant advances in chemistry and the life sciences. They should also represent a departure from current research directions rather than an extension or expansion of existing programs. Proposed research that cuts across traditional boundaries of scientific disciplines is encouraged. Proposals that open new avenues of research in chemistry and life sciences by fostering the invention of methods, instruments and materials will be given additional consideration.

    Eligibility: The BYI program is open to those within the first three years of a tenure-track position, or an equivalent independent research appointment, at a United States academic or non-profit institution that conducts research in chemical and life sciences. Tenure Track Start Date must be after: 8/14/2014 Candidates must be citizens or permanent residents of the United States at the time of application. Persons who have applied for permanent residency but have not received their government documentation by the time of application are not eligible. No individual may apply for a Beckman Young Investigator award more than two times. Investigators can have no more than $225,000 in direct, annualized external funding grants during any BYI Program Year (Aug-July) at time of application. Start-up funds, department-wide instrumentation grants, and "Transition" grants (such as NIH K99/R00) are not counted toward this total. Institutions are not limited in the number of applicants who apply at the Letter of Intent stage. Institutions with a currently funded BYI are eligible for award consideration.

    Amount: Grants typically range around $600,000 over the term of the project. Projects are normally funded for a period of four years

    Deadline: August 14, 2017

    RFP

  • Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33)

    The purpose of this FOA is to support the early stage testing of pharmacologic interventions with novel mechanisms of action, or device-based interventions, for the treatment of symptoms or domains of altered functions in individuals with mental illness (e.g. schizophrenia, depression, autism, obsessive compulsive disorder, anxiety, bipolar disorder, etc.). Early intervention studies are also encouraged where symptoms of a disorder have been identified in subjects (a prodromal phase), prior to full diagnostic criteria being met. Ultimately, this FOA is intended to support early stage testing of pharmacologic or device-based interventions using a protocol design where the presumed mechanism of action of the intervention is adequately tested, to provide meaningful information where target modulation yields a dose-dependent neurophysiological/clinical/behavioral effect. The R61/R33 FOAs are intended to support biphasic high risk applications. Applicants looking for a single phased award that does not need the developmental (R61) phase should apply to companion RFA-MH-17-602. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are encouraged to apply for support.

    Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project

    Letter of Intent Deadline: 30 days prior to the application deadline

    Application Deadline(s): October 17, 2017; February 14, 2018; June 15, 2018; October 15, 2018

    RFP

  • Bioengineering Research Grants (BRG) (R01)

    The purpose of this FOA is to encourage collaborations between the life and physical sciences that: 1) apply a multidisciplinary bioengineering approach to the solution of a biomedical problem; and 2) integrate, optimize, validate, translate or otherwise accelerate the adoption of promising tools, methods and techniques for a specific research or clinical problem in basic, translational, or clinical science and practice. An application may propose design-directed, developmental, discovery-driven, or hypothesis-driven research and is appropriate for small teams applying an integrative approach to increase our understanding of and solve problems in biological, clinical or translational science. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are encouraged to apply for support.

    Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project

    Deadline(s): 10/5/2017, 2/5/2018, 6/5/2018, 10/5/2018, 2/5/2019

    RFP

  • NEI Center Core Grant for Vision Research (P30)

    The National Eye Institute (NEI) Center Core Grant combines three or more Resource and/or Service Cores for a group of R01 investigators to enhance their research, consolidate resources, avoid duplication of efforts, and/or contribute to cost effectiveness by providing a service with lower costs or higher quality than could be attempted for independent projects by several individual Program Directors/Principal Investigators (PD(s)/PI(s)). Shared resources and facilities that are accessible to a group of independently funded investigators lead to greater productivity for the separate projects and can provide instrumentation and facilities that are too costly to be maintained by an individual investigator. The design and purpose of each Center Core may vary in how it serves its users. This program is designed to enhance an institution's environment and capability to conduct vision research and to facilitate collaborative studies of the visual system and its disorders. Only one application per institution is allowed.

    Amount: The NEI will provide direct costs of up to $2,000,000 over a five-year period in support of a Core Grant to institutions having 8 to 19 eligible grants. Institutions having 20 or more eligible grants may receive direct costs of up to $2,500,000 over a five-year period

    Deadline(s): September 28, 2017; September 28, 2018, September 18, 2019

    RFP

  • NARSAD Distinguished Investigator Grant

    The National Alliance for Research on Schizophrenia and Depression (NARSAD) Distinguished Investigator Grants, awarded through the Brain & Behavior Research Foundation, provide support for experienced investigators (full professor or equivalent) conducting neurobiological and behavioral research. One-year grants of $100,000 each are provided for established scientists pursuing particularly innovative project ideas. Distinguished Investigator Grants fund talented, established scientists with a record of outstanding research accomplishments. These research projects might provide new approaches to understanding or treating severe mental illness. If successful, the grants could result in later funding from other sources. These grants are among the most competitive in mental health research and demonstrate the power of investigator-initiated research to bring out new and creative ideas. Applicants 1) Must be full professors (or equivalent) and maintain peer reviewed, competitively-funded scientific programs; 2) May not receive the award for a second time.

    Amount: $100,000

    Deadline: July 19, 2017

    RFP

  • SFARI Autism Research Awards

    The mission of the Simons Foundation Autism Research Initiative (SFARI) is to improve the understanding, diagnosis and treatment of autism spectrum disorders (ASD) by funding innovative research of the highest quality and relevance. SFARI is currently seeking applications for the following awards:

    - Bridge to Independence Award RFP

    - Explorer Award RFP

    For more information regarding these awards, please click here.

  • Sloan Research Fellows - Neuroscience

    The Alfred P. Sloan Foundation is a not-for-profit grantmaking institution that supports high quality, impartial scientific research; fosters a robust, diverse scientific workforce; strengthens public understanding and engagement with science; and promotes the health of the institutions of scientific endeavor. The Sloan Research Fellowships seek to stimulate fundamental research by early-career scientists and scholars of outstanding promise. Candidates must hold a tenure track (or equivalent) position at a college, university, or other degree-granting institution in the United States or Canada. Tenure track faculty positions at the candidate's institution must include a yearly teaching requirement. Candidates' most recent Ph.D. (or equivalent) must have been awarded on or after September 1, 2011.

    Amount: $65,000

    Deadline: September 15, 2017

    RFP

  • DoD FY17 Peer Reviewed Cancer Research Program Awards

    The goal of the U.S. Department of Defense Peer Reviewed Cancer Research Program (PRCRP) is to improve quality of life by decreasing the impact of cancer on active duty Service members, their families, and the American public. The PRCRP is charged by Congress with the mission to investigate cancer risks and knowledge gaps that may be relevant to active duty Service members, their families, other military beneficiaries, and the American public. To be considered for funding, applications must address at least one of the FY17 PRCRP Topic Areas and at least one of the FY17 PRCRP Military Relevance Focus Areas, which can be found here.

    The PRCRP is seeking pre-applications for the following awards:

    - Career Development Award RFP

    - Idea Award with Special Focus RFP

    - Translational Team Science Award RFP

    A Letter of Intent is required. Application submissions accepted by invitation only.

    For more information regarding these awards, please click here.

  • SU2C Dream Team Translational Cancer Research Grant

    Stand Up To Cancer (SU2C), in partnership with the American Association for Cancer Research, is inviting Letters of Intent for a new $10 million "Dream Team" grant. Unlike other "Dream Team" grant opportunities offered by SU2C in recent years, the SU2C Dream Team Translational Cancer Research Grant program is open to any type of translational cancer research. The program will support a single translational cancer research project that addresses a critical problem in patient care and has the potential to deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional, expert team of investigators.

    The proposed project may focus on a particular organ site, patient population (e.g., pediatrics), or innovative method of treatment. The project must be designed to accelerate the application of a new preventive, diagnostic, or therapeutic approach to the clinic that leads to patient involvement within two to three years from the beginning of the grant. In addition, through collaboration with leading healthcare research and innovation center OptumLabs, the team will have the opportunity to gain access to and conduct research using OptumLabs' proprietary database of de-identified medical claims and electronic health record clinical data, analytic tools, and research. To maximize creativity, innovation, and collaboration, the team of investigators must include laboratory and clinical researchers, senior and/or young investigators, and senior scientists who have not worked together in the past.

    Amount: $10,000,000

    Letter of Intent Deadline: September 5, 2017 - 11:00 am CST

    Proposals accepted by invitation only.

    RFP

  • Funderburg Research Award in Gastric Cancer

    The AGA Foundation, the philanthropic arm of the American Gastroenterological Association, is inviting applications for the Robert & Sally Funderburg Research Award in Gastric Cancer. The annual award is designed to support an established investigator whose research has the potential to enhance the fundamental understanding of gastric cancer pathobiology and ultimately lead to the prevention of or a cure for the disease. The recipient will be selected based on novelty, feasibility, and significance of his/her proposal.

    A single grant of up to $100,000 over two years will be awarded to an established investigator working on novel approaches in gastric cancer research, including the fields of gastric mucosal cell biology, regeneration and regulation of cell growth (not as it relates to peptic ulcer disease or repair), inflammation (including Helicobacter pylori) as precancerous lesions, genetics of gastric carcinoma, oncogenes in gastric epithelial malignancies, epidemiology of gastric cancer, etiology of gastric epithelial malignancies, or clinical research with respect to the diagnosis or treatment of gastric carcinoma. To be eligible, applicants must hold a full-time faculty position at an accredited institution in North America and be established as an independent investigator in the field of gastric biology. AGA membership is required at the time of application submission, and women and minority investigators are strongly encouraged to apply.

    Amount: Up to $100,000

    Deadline: August 4, 2017

    RFP

  • National Blood Foundation - Scientific Research Grants Program

    The National Blood Foundation (NBF), has announced the 2018 grant program for scientific research projects related to transfusion medicine and cellular therapies.

    NBF will award grants for investigator-initiated original research focused on any aspect of blood banking, transfusion medicine, cellular therapies, or patient blood management. Grants will support one- or two-year research projects with a maximum award of $75,000. Awards will not be made to increase the funding available for currently funded research projects. NBF grants are intended to provide seed funding that allows the principal investigator to enhance his/her preliminary data so that is useful in applying for bigger grants.

    An application fee of $160 must accompany the application unless the primary investigator is an AABB individual member. To be eligible, an applicant must be a doctor (MD or PhD), medical technologist, or transfusion medicine or cellular therapies professional. All applicants will be considered regardless of age, race, gender, national origin, or religion.

    Amount: $75,000

    Deadline: December 1, 2017 – 10:59 pm CST

    RFP

  • AAFPF Joint Grant Awards Program

    The American Academy of Family Physicians Foundation (AAFPF), through its Joint Grant Awards Program (JGAP), supports research of one- to two-year duration that poses questions of high relevance to family medicine. The maximum JGAP grant award is $50,000. Applications for smaller-scale studies with lower costs are also welcome. To be eligible, the principal investigator must be a family medicine researcher, either a clinician or PhD. In addition, the PI or a co-investigator must be a member of AAFP. Priority will be given to new researchers or those who mentor new investigators on the research team. Education and healthcare institutions or organizations that intend to use JGAP support exclusively for research projects directly involving and impacting family medicine are also eligible.

    Amount: $50,000

    Deadline: January 9, 2018

    RFP

  • NINDS Exploratory Clinical Trials for Small Business (R42)

    The purpose of this FOA is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Technology Transfer (STTR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The projects must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Only STTR Phase II and Fast-Track applications are supported under this program. STTR Phase I applications are only accepted as part of a Fast-track application. Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity.

    Amount: According to statutory guidelines, total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50% ($225,000 for Phase I and $1,500,000 for Phase II). However, NIH can apply for a waiver from SBA to issue an award exceeding these amounts under appropriate circumstances. Applications should rarely exceed $1,000,000 in total cost per year for a Phase I and $1,500,000 in total cost per year for a Phase II.

    Deadline(s): September 5, 2017; January 5, 2018; April 5, 2018

    RFP

  • Global Brain and Nervous System Disorders Research Across the Lifespan (R01, R21)

    This FOA encourages grant applications for the conduct of innovative, collaborative research projects between U.S. and low- and middle-income country (LMIC) scientists, on brain and other nervous system function and disorders throughout life, relevant to LMICs (including neurological, mental, behavioral, alcohol and substance use disorders and spanning the full range of science from basic to implementation research). Scientists in upper middle-income LMICs (UMICs) are also eligible to partner directly with scientists at other LMIC institutions with or without out a US partner. Income categories are defined by the World Bank. The collaborative research programs are expected to contribute to the long-term goals of building and strengthening sustainable research capacity in LMICs to address nervous system development, function and impairment throughout life and to lead to diagnostics, prevention, treatment and implementation strategies. The proposed work will also contribute to developing a base for research networking and evidence-based policy beyond the specific research project. 

    Research Project Grant (R01)

    Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project

    RFP

    Exploratory/Developmental Research Grant Award (R21)

    Amount: Application budgets are limited to $125,000 per year in direct costs, but must reflect the actual needs of the proposed project

    RFP

    Letter of Intent Deadline (for both awards): 30 days prior to the application deadline

    Application Deadline(s) (for both awards): November 7, 2017; November 7, 2018; November 7, 2019

    For more information regarding eligibility, please click here.

  • DoD Parkinson’s Research Program Awards

    The U.S. Department of Defense is seeking applications for the following FY17 Parkinson's Research Program (PRP) Awards:

    - Investigator-Initiated Research Award RFP

    - Early Investigator Research Award RFP

    Letter of Intent Deadline (for both awards): August 17, 2017

    Application Deadline (for both awards): August 31, 2017

    For more information regarding these awards, please click here.

  • NINDS Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25)

    The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NINDS Neuroscience Development for Advancing the Careers of a Diverse Research Workforce R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral and clinical research workforce by (1) increasing the pool of current and future Ph.D.-level research scientists from diverse backgrounds underrepresented in biomedical neuroscience research; and (2) facilitating the career advancement/transition of the participants to the next step of their neuroscience careers. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on NINDS-relevant research experiences, mentoring activities that enhance compentencies or leadership education and courses on skills development. Programs that target transitions and/or more than one career stage for neuroscience career advancement and progression are strongly encouraged. NINDS support for this R25 program relies equally on scientific merit and programmatic considerations. Consequently, it is recommended that potential applicants contact Scientific/Research staff at NINDS before preparing an application. NINDS will not support projects if they do not fulfill current programmatic priorities at NINDS.

    For additional information regarding eligibility, please click here.

    Amount: Application budgets are limited to a maximum of $250,000 direct cost per year, and must reflect the actual needs of the proposed project

    Letter of Intent Deadline: At least 30 days prior to application deadline

    Application Deadline(s): September 25, 2017, September 25, 2018, September 25, 2019

    RFP

  • DoD Autism Research Program Awards

    The U.S. Department of Defense is seeking pre-applications for the following FY17 Autism Research Program (ARP) Awards:

    - Idea Development Award RFP

    - Clinical Translational Research Award RFP

    - Clinical Trial Award RFP

    Letter of Intent Deadline (for all 3 awards): July 26, 2017

    Application submissions accepted by invitation only. All organizations, including international organizations, are eligible to apply.

    For more information regarding these awards, please click here.

  • FY2018 Office of Naval Research (ONR) Young Investigator Program (YIP)

    The Office of Naval Research (ONR) is interested in receiving proposals for its Young Investigator Program (YIP). ONR's YIP seeks to identify and support academic scientists and engineers who are in their first or second full-time tenure-track or tenure-track equivalent academic appointment, have begun their first appointment on or after December 31, 2012, and who show exceptional promise for doing creative research. The objectives of this program are to attract outstanding faculty members of Institutions of Higher Education to the Department of the Navy's Science and Technology (S&T) research program, to support their research, and to encourage their teaching and research careers. Proposals which address the ONR S&T research areas will be considered. The PI of a proposal must be a U.S. citizen, national, or permanent resident (on the date proposals are due), holding a first or second full-time tenure-track or tenure-track-equivalent faculty position at that university, and has begun her/his first full-time appointment on or after December 31, 2012. Proposed research should be structured to have a three (3) year period of performance beginning June 1, 2018.

    Amount:  It is anticipated that individual awards will be up to $170,000 per year for three (3) years (with the possibility of greater support for equipment and/or to support additional, collaborativeresearch with a Navy laboratory). The $170,000 limit includes all funds paid to the university, including all indirect costs.

    Deadline: September 15, 2017

    RFP

  • DoD Spinal Cord Injury Research Program Awards

    The U.S. Department of Defense is seeking pre-applications for the following FY17 Spinal Cord Injury Research Program (SCIRP) Awards:

    - Qualitative Research Award RFP

    - Translational Research Award RFP

    - Clinical Trial Award RFP

    - Clinical Research Development Award RFP

    - Investigator-Initiated Research Award RFP

    Letter of Intent Deadline (for all 5 awards): August 8, 2017

    Application submissions accepted by invitation only. All organizations, including international organizations, are eligible to apply.

    For more information regarding these awards, please click here.

  • Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01, R21)

    The National Cancer Institute (NCI) encourages applications for transdisciplinary research that will leverage cognitive neuroscience to improve traditional measurement of cognitive impairment following cancer treatment, often referred to as “chemobrain.” A better understanding of the acute- and late-term cognitive changes following exposure to adjuvant chemotherapy and molecularly-targeted treatments, including hormonal therapy, for non-central nervous system tumors can inform clinical assessment protocols with downstream implications for survivorship care plans. Underrepresented groups encouraged to apply.

    Research Project Grant (R01)

    Amount: Application budgets should reflect the actual needs of the proposed project (5 year maximum project period)

    Deadline(s): October 10, 2017; April 11, 2018; October 10, 2018; April 11, 2019

    RFP

    Exploratory/Developmental Research Grant Award (R21)

    Amount: The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year

    Deadline(s): October 10, 2017; April 11, 2018; October 10, 2018; April 11, 2019

    RFP

  • NeuroNEXT Small Business Innovation in Clinical Trials (U44)

    The National Institute of Neurological Disorders and Stroke (NINDS) encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing clinical studies. Diseases chosen for study should be based on the NINDS' strategic plan and clinical research interests, which can be found here. Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity.

    Amount: According to statutory guidelines, total funding support (direct costs, indirect costs, fees) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50% as a hard cap ($1,500,000 for Phase II). However, NIH has received a waiver from SBA, as authorized by statute, to exceed the hard cap of $1,500,000 for Phase II for specific topics. The current list of approved topics can be found here. Applicants should rarely exceed $1,000,000 in total cost per year for a Phase I and $1,500,000 in total cost per year for a Phase II/Phase IIB.

    Deadline(s): 9/5/2017, 1/5/2018

    RFP

  • DoD Neurofibromatosis Research Program Awards

    The vision of the FY17 U.S. Department of Defense Neurofibromatosis Research Program (NFRP) Awards is to decrease the clinical impact of NF. Toward this end, the NFRP seeks to support innovative, high-impact research that will foster new directions for and address neglected issues in NF research; sponsor multidisciplinary and multi-institutional collaborations that will bring new perspectives to the field; promote translational and clinical studies to move promising ideas from bench to bedside; and develop a balanced portfolio of meritorious research related to all aspects of NF1, NF2, and schwannomatosis. 

    The NFRP seeks applications for the following:

    - Clinical Trial Award RFP

    - New Investigator Award RFP

    - Exploration-Hypothesis Development Award RFP

    - Investigator-Initiated Research Award RFP

    Pre-Application Deadline (for all 4 awards): July 26, 2017

    Application Deadline (for all 4 awards): August 9, 2017

    All organizations, including international organizations, are eligible to apply.

    For more information regarding these awards, please click here.

  • Paralyzed Veterans of America Research Grant

    From transplanting cells to regenerating damaged nerve fibers to designing adaptive canoe seats, the Paralyzed Veterans of America Research Foundation (PVA) supports innovative research and fellowships that improve the lives of those with spinal cord injury and disease (SCI/D). The Research Foundation, a 501(c)(3) nonprofit, funds the following categories: Laboratory research in the basic sciences to find a cure for SCI/D; Clinical and functional studies of the medical, psychosocial and economic effects of SCI/D, and interventions to alleviate these effects; Design and development of assistive technology for people with SCI/D, which includes improving the identification, selection and utilization of these devices; and Fellowships for postdoctoral scientists, clinicians and engineers to encourage training and specialization in the field of spinal cord research.

    Eligible grantee institutions must be located in the United States or Canada. However, investigators and fellows are not required to be U.S. or Canadian citizens. All grant applicants must have a professional degree: Ph.D. or M.D. preferred, master’s degree acceptable under some circumstances. Senior fellows are encouraged to apply as principal investigators. Post-doctoral individuals are eligible to apply for fellowship support within four years of receiving a Ph.D. or completing M.D. residency.

    Amount: $75,000

    Deadline: 7/24/2017

    RFP

  • Neuroscience Research on Drug Abuse (R01, R21)

    The National Institute on Drug Abuse (NIDA) encourages Research Project Grant (R01) and Exploratory/Developmental Research Grant Award (R21) applications regarding neuroscience research on drug abuse. Long-term misuse and chronic exposure to abused substances can produce widespread changes in brain structure and function. Although much progress has been made, additional research is still needed to identify the neurobiological changes that result from substance use, and how these changes contribute to substance use disorders. The overarching goals of the research areas described in these FOAs are to understand the neurobiological mechanisms underlying substance use disorders, with special emphasis on identifying changes and neuroadaptations that occur during dependence, withdrawal, and relapse to chronic substance use. An understanding of the basic mechanisms underlying substance use disorders can help to identify targets for prevention and treatment interventions. Research utilizing basic, translational, or clinical approaches is appropriate. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for support.

    Research Project Grant (R01)

    Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project (5 year maximum project period)

    Deadline(s): 10/5/2017, 2/5/2018, 6/5/2018, 10/5/2018, 2/5/2019, 6/5/2019, 10/5/2019

    RFP

    Exploratory/Developmental Research Grant Award (R21)

    Amount: Direct costs are limited to $275,000 over a two-year period, with no more than $200,000 in direct costs allowed in any single year

    Deadline(s): 10/16/2017, 2/16/2018, 6/16/2018, 10/16/2018, 2/16/2019, 6/16/2019, 10/16/2019

    RFP

  • 2017 Histiocytosis Research Grants

    The Histiocytosis Association is a global nonprofit organization dedicated to addressing the unique needs of patients and families dealing with the effects of histiocytic disorders, a group of diseases that occur when there is an over-production of white blood cells known as histiocytes that can lead to organ damage and tumor formation in both children and adults. The only organization of its kind, HA works to encourage the patient and medical communities to improve and share knowledge of histiocytic disorders; provide critical emotional and educational support to patients and families; and identify and fund key research initiatives that lead to a world free of histiocytic disorders.

    To that end, the foundation will award grants of up to $50,000 for research on the causes, mechanisms, and improved means of treatment for histiocytic disorders.  While all areas of research relevant to the histiocytoses will be considered, priority will be given to studies related to mechanisms of disease pathogenesis; biology (maturation, migration, and immune function) of dendritic cells, macrophages, and/or lymphocytes in disease pathogenesis; derangements of cytokine production or function; CNS pathology; neuropsychiatric consequences; studies of rare forms (juvenile xanthogranuloma, Erdheim-Chester disease, Rosai-Dorfman disease); studies of histiocytic disorders in adults; and discovery of new disease markers.

    Amount: Up to $50,000

    Deadline: July 1, 2017

    RFP

  • Duchenne Muscular Dystropy Research Program Awards

    The Department of Defense Duchenne Muscular Dystrophy Research Program (DMDRP) was initiated in 2011 to provide suport for research of exceptional scientific merit and to promote the understanding, diagnosis, and treatment of Duchenne. Applications for the following FY17 awards are solicited:

    - Career Development Award RFP

    - Investigator-Initiated Research Award RFP

    For more information, please click here.

  • Research in Nanomanufacturing Materials and Processes

    Semiconductor Research Corp. (SRC) Global Research Collaboration (GRC) is soliciting white papers in the research program of Nanomanufacturing Materials and Processes. The principal goals of this program are to advance fundamental knowledge and innovations in the nanomanufacturing of semiconductors.

    This call, issued to universities worldwide, may be addressed by an individual investigator or a research team. The selection process is divided into two stages. The interested party is requested to submit a brief two-page white paper. The white paper should clearly identify what can be done in the total length of project; either two years or three years. A successfully selected white paper will result in an invitation to submit a full proposal. These proposals will be further down-selected for research contracts.

    Proposals offering funding leverage are strongly encouraged and should be indicated. (Leverage is other funding resources related and beneficial to the proposed work.) Due to the expected large number of submissions, we request that each researcher is limited to one submission bearing the best potential.

    Amount: The number and size of the contracts awarded will be determined by the amount of available funds, and by the number of high-quality proposals. The anticipated funding level per task is expected to be in the range of $80K to $100K per year, which includes the overhead expenses charged by the institution.

    Deadline: July 18, 2017 (white paper)

    Proposal submissions accepted by invitation only.

    RFP

  • Migraine Research Grants

    The Migraine Research Foundation (MRF), in partnership with the Association of Migraine Disorders (AMD), has issued a Request for Proposals for migraine research projects. MRF is committed to discovering the causes, improving the treatments, and finding a cure, and AMD stimulates increased research specifically in the area of migraine disorders. The funders are looking for projects that will help sufferers by advancing our ability to understand and treat migraine. As a result, they will provide seed money grants for transformational projects that will lead to better treatment and quality of life for sufferers of migraine and migraine disorders.

    While the funders welcome all proposals relevant to basic or clinical migraine research, they are particularly interested in translational projects and those related to migraine variants, childhood migraine, and chronic migraine. Grants of up to $50,000 will be awarded in support of relevant migraine research, with priority given to translational projects and projects related to migraine variants, childhood migraine, and chronic migraine. Grant funds must be used exclusively for research and directly related research equipment. Capital expenditures, administrative costs, and institutional overhead (including IRB approval, publication costs, and travel costs) will not be funded.

    Amount: Up to $50,000

    Deadline: July 28, 2017

    RFP

  • American Hearing Research Foundation Regular Grants

    The American Hearing Research Foundation is accepting applications to its AHRF Regular Grants program.

    One-year grants of up to $40,000 will be awarded to projects that investigate various aspects of hearing and balance disorders related to the inner ear. Priority will be given to investigators early in their careers who need seed funds to generate results and data that can be used to support applications for larger grants (i.e., NIH grants) in the future.

    Projects should relate to the hearing or balance functions of the ear. Both basic and clinical studies that investigate aspects of the auditory and vestibular systems, including but not limited to genetics, neurotology, anatomy, auditory processing, molecular and cellular biology, therapeutic studies, and investigations of current or experimental devices (i.e., cochlear implants), may be proposed.

    Funding may only be used for direct costs, including salaries of technical and supporting staff, equipment related to the research, and supplies. The grants will not support the salary of the principal investigator, travel or conference attendance, or educational costs.

    Amount: Up to $40,000

    Deadline: August 15, 2017

    RFP

  • Accelerating Drug Discovery for Frontotemporal Degeneration

    The Alzheimer's Drug Discovery Foundation, in partnership with the Association for Frontotemporal Degeneration, has issued a Request for Proposals for innovative research on FTD, a disease process that results in progressive damage to the temporal and/or frontal lobes of the brain.

    Grants of up to $150,000 will be awarded for research on the pathologic mechanisms underlying FTD. Priority will be given to projects related to the development and testing of novel high-throughput screening assays; identification and in vitro testing of potentially disease modifying compounds or biologics, including medicinal chemistry refinement, ADME, toxicology, pharmacokinetics, and pharmacodynamics studies; testing of novel lead compounds, biologics, or repurposed drug candidates in a relevant animal model for preclinical proof of concept; and/or development and/or characterization of new model organisms or cellular models in support of drug-discovery efforts. Funding is provided through mission-related investments that require return on investment based on scientific and/or business milestones.

    To be eligible, applicants must be an academic investigator seeking to create and support innovative translational programs in an academic medical center, university, or biotechnology company with programs dedicated to neurodegenerative disease translational development. New biotechnology company spinouts or existing biotechnology companies that demonstrate a clear need for nonprofit funding also are eligible to apply.

    Amount: Up to $150,000

    Deadline for Letter of Intent: July 31, 2017

    Proposal submissions accepted by invitation only.

    RFP

  • Scleroderma Foundation Grants

    The Scleroderma Foundation wants to foster development of innovative, high-quality research by new and established investigators in fields related to scleroderma. To accomplish this goal, the Foundation is seeking applications for the following programs:

    - New Investigator Grant Program RFP

    - Established Investigator Grant Program RFP

    Applications will be accepted from principal investigators at nonprofit organizations and public and private entities such as universities, colleges, hospitals, and laboratories. Applicants must have a doctoral degree in medicine, osteopathy, veterinary medicine, or one of the sciences; have completed a postdoctoral fellowship; and have been principal investigator on a grant from the Scleroderma Foundation or other national, private, or government agencies in the past.

    Deadline (for both programs): September 15, 2017 - 4:00 CST

    For more information, please click here.

  • Desmoid Tumor Research Foundation - Young Investigator Grants

    The Desmoid Tumor Research Foundation (DTRF) funds research that uses cutting-edge science and creative clinical applications, as well as novel approaches that address potential leads based on prior research. As part of this mission, DTRF has issued a Request for Proposal to support early-stage research that explores new approaches to advance current scientific knowledge about desmoid tumors resulting in the development of new treatment options and bringing us closer to a cure.

    One-year grants of up to $30,000 will be awarded to young investigators (at the rank of Associate Professor or below) who are new to desmoid tumor research and require seed funding that enables them to gather preliminary data needed to apply for funding to support a more fully developed line of research in the future. Researchers must be willing to collaborate with other scientists and institutions with similar interests.

    Amount: Up to $30,000

    Deadline: January 12, 2018

    RFP

  • Gulf War Illness Research Program Awards

    The U.S. Department of Defense Congressionally Directed Medical Research Programs (CDMRP) is seeking pre-applications for FY17 Gulf War Illness Research Program (GWIRP) Awards:

    - Biorepository Resource Network Award RFP

    - Clinical Consortium Award RFP

    - Investigator-Initiated Focused Research Award RFP

    - Qualitative Research Award RFP

    Letter of Intent Due Date (for all 4 awards): June 30, 2017

    Application submissions accepted by invitation only. For more information, please click here.

  • Damon Runyon Cancer Research Foundation Awards

    The Damon Runyon Cancer Research Foundation identifies scientists with the highest potential to revolutionize how all forms of cancer are prevented, diagnosed, and treated.

    The Foundation is accepting applications for the following awards:

    - 2017 Physician-Scientist Training Award RFP

    - 2017 Damon Runyon-Rachleff Innovation Award RFP

    For more information, please click here.

  • 2017 Psychosocial Grant Progam - Alex's Lemonade Stand Foundation

    Alex's Lemonade Stand Foundation (ALSF) evolved from the front yard lemonade stand of cancer patient Alexandra “Alex” Scott (1996-2004) into a national fundraising movement to research and identify new treatments and cures for all childhood cancer patients and to help improve the quality of life and care for children and families affected by childhood cancer.

    The Alex's Lemonade Stand Foundation is accepting Letters of Intent for two categories of grants through its Psychosocial Grant program.

    1) Psychosocial Launch Grants: Launch grants are designed for early-career researchers within seven years of receiving their terminal degree. Grants of up to $100,000 over two years will be awarded to support studies that aim to explain and/or improve psychosocial outcomes for those affected by childhood cancer. 

    2) Psychosocial Family Impact Grants: Family Impact grants are designed for established investigators. Grants of up to $300,000 over three years will be awarded for studies that aim to explain and/or improve psychosocial outcomes for those affected by childhood cancer. These grants are designed to fund researchers who have novel approaches to understanding the psychosocial aspects of pediatric cancer and whose proposals are likely to have clinically significant impact.

    Amount: Up to $300,000 over three years

    Deadline: June 9, 2017

    RFP

  • Elton John HIV/AIDS Projects

    The Elton John AIDS Foundation is accepting Letters of Intent from organizations working with people who are most affected by HIV.

    Grants will be awarded to organizations working to improve the health of people living with HIV or at risk or otherwise affected by HIV; uphold the rights of people living with and affected by HIV; address the social and economic needs of people living with and affected by HIV; and/or strengthen the skills and strategies of organizations and activists working to address HIV.

    Priority will be given to organizations that are led by and based in the communities being served; advocate for improved government health policies and funding; are piloting or scaling innovative programs to promote health and rights; can show a history of activism, creativity, and urgency in working to address and curtail the HIV epidemic; and are grounded in evidence about where and among whom HIV infections are happening, as well as evidence about the most effective ways to help people avoid infection or, if they're already HIV-positive, to live healthy lives.

    Amount: Past grants ranged from $10,000 to $100,000

    Letter of Intent Due Date: June 30, 2017

    Proposal submissions accepted by invitation only.

    RFP

  • Young Investigator – Spinocerebellar Ataxia Research Award

    The National Ataxia Foundation (NAF) created the Young Investigator-SCA Award to encourage young clinical and scientific investigators to pursue a career in the field of spinocerebellar ataxia (SCA) research. It is the hope of the NAF that ataxia research will be invigorated by the work of young, talented individuals supported by this award.

    Amount: $50,000

    Letter of Intent Due Date: August 1, 2017

    Due Date: September 1, 2017

    RFP

  • Claude D. Pepper Older Americans Independence Centers (P30)

    This FOA supports applications for Claude D. Pepper Older Americans Independence Centers (OAICs), centers of excellence in geriatrics research and research education to increase scientific knowledge leading to better ways to maintain or restore independence in older persons. The OAIC awards are designed to develop or strengthen awardee institutions’ programs that focus and sustain progress on a key area in aging research related to the mission of the OAIC program. Only one application per institution is allowed.

    Amount: Application budgets are limited to $825,000 in annual direct costs

    Letter of Intent Due Date: September 19, 2017

    Due Date: October 19, 2017

    RFP

  • Integrating Biology and Social Science Knowledge (BioSS)

    The Russell Sage Foundation (RSF), in collaboration with the Ford Foundation, will support innovative social science research on social and economic outcomes that improves understanding of the interactive mechanisms by which environmental influences affect biological mechanisms, and vice versa. This includes research that: (1) estimates how the structured nature of the social environment and intra- and intergenerational social inequalities affect biological processes, (2) identifies which indicators of biological processes interact with the social environment to affect different life domains and how, and (3) yields new conceptual frameworks that holistically characterize the complex relationships among biological, psychological and environmental factors to predict a range of behavioral and social outcomes. The funders are primarily interested in research that explores and improves understanding of social and economic predictors and outcomes.

    All applicants (both PIs and Co-PIs) must have a Ph.D. or comparable terminal degree, or a strong career background that establishes their ability to conduct high-level, peer-reviewed scholarly research. RSF particularly encourages early career scholars to apply for Presidential awards. All nationalities are eligible to apply and applicants do not have to reside in the U.S.

    Amount: Applications should limit budget requests to no more than a two-year period, with a maximum of $150,000 per project (including overhead). Presidential Awards, with a maximum budget of $35,000 ($50,000 if new data collection/access is included; no overhead allowed) are also available. 

    Letter of Intent Due Date(s): August 21, 2017 & May 31, 2018

    Application submissions accepted by invitation only.

    RFP

  • Alcohol-Induced Effects on Tissue Injury and Repair (R01 & R21)

    The National Institute on Alcohol Abuse and Alcoholism (NIAAA) encourages Research Project Grant (R01) and Exploratory/Developmental Research Grant Award (R21) applications to study molecular and cellular mechanisms of tissue injury and repair associated with alcohol use in humans. Excessive alcohol consumption has the potential to adversely affect multiple organ systems including the liver, brain, heart, pancreas, lung, kidney, endocrine and immune systems, as well as bone and skeletal muscle. In addition, there is accumulating evidence that long term alcohol consumption is associated with reduced host capacity for recovery and repair following trauma. The mechanisms for these alcohol-induced effects on tissue injury and repair are currently not fully understood. NIAAA is especially interested in integrative research that elucidates alcohol’s effects on complex mechanisms of injury and repair that are either common or specific to each organ system. This FOA also encourages the study of alcohol’s effect on stem cells, embryonic development, and regeneration. Also encouraged are studies on molecular and cellular actions of moderate alcohol consumption. A better understanding of these underlying mechanisms may provide new avenues for developing more effective and novel approaches for prognosis, diagnosis, intervention, and treatment of alcohol-induced organ damage. Underrepresented groups encouraged to apply.

    Research Project Grant (R01)

    Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project.

    Due Date(s): 6/5/2017, 10/5/2017, 2/5/2018, 6/5/2018, 10/5/2018, 2/5/2019, 6/5/2019, 10/5/2019, 2/5/2020, 6/5/2020

    RFP

    Exploratory/Developmental Research Grant Award (R21)

    Amount: The combined budget for direct costs for the two year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.

    Due Date(s): 6/16/2017, 10/16/2017, 2/16/2018, 6/16/2018, 10/16/2018, 2/16/2019, 6/16/2019, 10/16/2019, 2/16/2020, 6/16/2020

    RFP

  • Psychological, Behavioral, and Neurocognitive-Focused Ancillary Studies to the Molecular Transducers of Physical Activity in Humans Consortium (MoTrPAC) (U01)

    The purpose of this FOA is to support an ancillary study grant application(s) to add psychological, behavioral, and/or neurocognitive assessments to the data collection in adults (> 18 years of age) enrolled at the clinical sites in the Molecular Transducers of Physical Activity in Humans Consortium (MoTrPAC) supported by the NIH Common Fund. This ancillary study FOA complements the parent MoTrPAC study by supporting research to elucidate the individual level psychological, behavioral, and neurocognitive characteristics that explain variation in individual response and adherence to a program of physical activity. The ultimate goal of the research supported by this FOA is to characterize individual differences in response to exercise over the course of the MoTrPAC protocol in order to identify novel treatment targets and inform personalized physical activity intervention approaches in the future. Underrepresented groups encouraged to apply.

    Amount: Application budgets are limited to $3,000,000 Direct Costs per year. This limit is exclusive of any Facilities and Administrative costs associated with consortium or subcontract agreements. Budgets are expected to reflect the actual needs of the proposed project.

    Letter of Intent Due Date: September 24, 2017

    Due Date: October 24, 2017

    RFP

  • NIA MSTEM: Advancing Diversity in Aging Research through Undergraduate Education (R25)

    The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIA R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral and clinical research workforce in aging. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Research Experiences  and Curriculum or Methods Development. 

    The PD/PI should be an established investigator in the scientific area in which the application is targeted and capable of providing both administrative and scientific leadership to the development and implementation of the proposed program. The PD/PI will be expected to monitor and assess the program and submit all documents and reports as required.

    Amount: Direct costs up to $350,000 per year may be requested.

    Letter of Intent Due Date: 8/25/17

    Due Date(s): 9/25/2017, 1/25/2018, 5/25/2018, 9/25/2018, 1/25/2019, 5/25/2019, 9/25/2019, 1/25/2020, 5/25/2020

    RFP

  • American Sleep Medicine Foundation (ASMF) Strategic Research Award

    This is a focused RFA soliciting applications in specific topic areas that will advance the field of sleep medicine. The topics for this RFA include: circadian rhythm sleep-wake disorders, hypopnea scoring criteria, pediatric sleep-disordered breathing, collaborative care models across specialties, telemedicine for sleep-disordered breathing, and treatments for narcolepsy and other disorders of hypersomnia. Studies of other high-impact areas of sleep research will also be considered.

    The applicant must be a member of the AASM in good standing.The applicant must possess a masters level degree or higher. The applicant must have access to the necessary resources (including the proposed patient population), facilities and other resources needed to perform the proposed work. Projects must be performed by United States based investigators and institutions. No projects outside the United States will be funded.

    Amount: $250,000 Category I; $100,000 Category II

    Letter of Intent Due Date: June 6, 2017

    Application submissions accepted by invitation only.

    RFP

  • Specialized Alcohol Research Centers (P50)

    This FOA invites applications for specialized Alcohol Research Centers using the P50 mechanism.  The overall purpose of the NIAAA Alcohol Research Center program is to provide leadership in conducting and fostering interdisciplinary, collaborative research on a wide variety of topics relevant to the Institute’s mission.  These topics include, but are not limited to: the nature, etiology, genetics, diagnosis, treatment, and prevention of alcohol use disorders and their biomedical, psychosocial, and economic consequences across the lifespan.  Centers also are regional or national resources that contribute to the development of new research methods, technologies and approaches that sustain innovative goal-directed research. Underrepresented groups encouraged to apply.

    Amount: Applications may not exceed $1.15 million direct costs per year.

    Letter of Intent Due Date: November 5, 2017

    Due Date: December 5, 2017

    RFP

  • Joint NSF/NIH Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD)

    The Quantitative Approaches to Biomedical Big Data Program is designed to support research that addresses important application areas at the intersection of the biomedical and data sciences by encouraging inter- and multi-disciplinary collaborations that focus on innovative and transformative approaches to address these challenges.

    Amount: Award sizes are expected to range from $200,000 to $300,000 (total costs) per year with durations of up to 3 years.

    Due Date: September 12, 2017

    RFP

  • DoD Multiple Sclerosis Research Program Awards

    The DoD Multiple Sclerosis Research Program seeks applications for Investigator-Initiated Research Awards and Exploration – Hypothesis Development Awards:

    Investigator-Initiated Research Award

    The Investigator-Initiated Research Award supports highly rigorous, high-impact research projects that have the potential to make an important contribution to MS research and/or patient care. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, clinical trial results, population-based studies, a clinician’s first hand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to MS and the proposed research project.

    Amount: Estimated total program funding $600,000,000 among 4 expected awards

    RFP

    Exploration – Hypothesis Development Award

    The Exploration – Hypothesis Development Award supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in the MS research field. The studies supported by this award mechanism are expected to lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well formulated, testable hypothesis based on strong scientific rationale and study design. The presentation of preliminary and/or published data is not required. Applications should include the anticipated direct costs budgeted for the entire period of performance for an FY17 MSRP.

    Amount: $6,000,000 estimated total program funding among 7 awards.

    RFP

    Letter of Intent Due Date (for both awards): June 26, 2017

    Application submissions accepted by invitation only.

  • NeuroNEXT Infrastructure Resource Access (X01)

    This FOA encourages applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing a future trial, for biomarker validation studies, or for proof of mechanism clinical studies. Diseases chosen for study should be based on the NINDS' strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm). Successful applicants will be given access to the NeuroNEXT infrastructure. Following peer review, NINDS will prioritize and order trials that are given access to the NeuroNEXT infrastructure. The NeuroNEXT Clinical Coordinating Center (CCC) will work with the successful applicant to efficiently implement the proposed study. The NeuroNEXT Data Coordinating Center (DCC) will provide statistical and data management support. The NeuroNEXT clinical sites will provide recruitment/retention support as well as on-site implementation of the clinical protocol.Applicants do not need to be part of the existing NeuroNEXT infrastructure. Underrepresented groups encouraged to apply.

    Amount: Not applicable, funds are not awarded via this X01 

    Due Date: Applications are accepted by continuous receipt until 11/13/2017

    RFP

  • NIA Academic Leadership Career Award (K07)

    The objective of the NIA Academic Leadership Career Award (K07) is to provide support for senior investigators who have the expertise and leadership skills to enhance aging and geriatric research capacity within their academic institution.

    By the time of award, the individual must be a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status.

    Amount: Award budgets are composed of salary and other program-related expenses

    Due Date(s): 6/12/2017, 10/12/2017, 2/12/2018, 6/12/2018, 10/12/2018, 2/12/2019, 6/12/2019, 10/12/2019, 2/12/2020, 6/12/2020

    RFP

  • Biomarkers Discovery In Parkinsonism (U01)

    The purpose of this FOA is to support hypothesis-driven research to discover human biomarkers in Parkinson’s disease and other Parkinsonian syndromes, as a component of the NINDS Parkinson’s Disease Biomarkers Program (PDBP). This FOA encourages biomarkers discovery projects in 1) genetically causal Parkinson's disease, especially for particular sub-types of Parkinson's Disease (PD), including genetic cohorts, biologically defined cohorts of idiopathic PD, or ethnic subgroups of idiopathic PD; 2) The differentiation of synucleinopathies (such as PD and Multiple System Atrophy (MSA) from tauopathies (such as Progressive Supranuclear Palsy and Corticobasal degeneration); or 3) to improve diagnostic differentiation between idiopathic/subtypes of PD and these disorders, as well as from Essential tremor. In order to further advance research in this area, broad sharing of biospecimens and associated data is a critical feature of the PDBP generally and of this FOA specifically. A timeline including milestones, which will be used to evaluate the application not only in peer review but also in consideration of the awarded project for funding of non-competing award years, is required for all studies. Underrepresented groups encouraged to apply.

    Amount: Not limited but need to reflect the actual needs of the proposed project

    Letter of Intent Due Date: 30 days prior to application due date

    Due Date(s): September 6, 2017 & September 6, 2018

    RFP

  • NIH StrokeNet Applications (U24, U01, X01, & U44)

    The National Institutes of Health (NIH) StrokeNet seeks the following applications:

    - Regional Coordinating Stroke Centers (U24) RFP

    - Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U01) RFP

    - Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention Infrastructure Resource Access (X01) RFP

    - Small Business Innovation Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U44) RFP

    For more information, click here.